Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents - Concepedia

Concepedia

Publication | Closed Access

Treatment of Very Early Rheumatoid Arthritis With Symptomatic Therapy, Disease-Modifying Antirheumatic Drugs, or Biologic Agents

96

Citations

41

References

2009

Year

Axel Finckh, Nick Bansback, Carlo A. Marra, Aslam H. Anis, Kaleb Michaud, Stanley Lubin, Marc White, Sonia Sizto, Matthew H. Liang

Annals of Internal Medicine

Abstract

According to the most objective measures of RA progression, very early intervention with conventional DMARDs is cost-effective. The cost-effectiveness of very early intervention with biologics remains uncertain.

References

	Year	Citations

Page 1